Ovarian Cancer in the Era of Immune Checkpoint Inhibitors: State of the Art and Future Perspectives

SIMPLE SUMMARY: Ovarian cancer (OC) represents the fifth leading cause of cancer-related deaths among women. In the advanced disease setting, OC recurrence after chemotherapy is over 70% in the first 2 years, with few therapeutic options. Immunotherapy with the immune checkpoint inhibitors (ICIs) sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Maiorano, Brigida Anna, Maiorano, Mauro Francesco Pio, Lorusso, Domenica, Maiello, Evaristo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430975/
https://www.ncbi.nlm.nih.gov/pubmed/34503248
http://dx.doi.org/10.3390/cancers13174438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430975/
https://www.ncbi.nlm.nih.gov/pubmed/34503248
http://dx.doi.org/10.3390/cancers13174438

Ejemplares similares